International Celiac Disease Symposium

描述（由申请人提供）： NIH关于乳糜泻的共识发展会议（2004年6月）得出结论，乳糜泻发生在约1%的美国人口中，尽管到目前为止大多数未被诊断。乳糜泻是一种独特的自身免疫性疾病，由于遗传决定的免疫不耐受面筋，小麦和类似谷物的储存蛋白的术语。目前唯一的治疗方法是无麸质饮食。位于纽约的哥伦比亚大学的腹腔疾病中心将于2006年11月主办第十二届腹腔疾病国际研讨会。这个一年两次的活动是一个论坛，来自地球仪的临床医生和研究人员聚集在一起，介绍目前的研究和交流有关这种疾病的知识。没有任何社团资助这一活动。每个国家的个别组织者获得资金。最近的NIH共识会议，加上对乳糜泻的科学和临床兴趣的增加，以及对非饮食疗法发展的兴趣，使本次研讨会成为美国医疗，科学和制药行业的重要事件，发生在一个关键时刻。此外，在发达国家和发展中国家，人们对乳糜泻的诊断和管理的兴趣也大大增加。我们组织了一次国际研讨会，来自世界各地的该领域领导人参加了研讨会。此外，将有一个临床论坛，专为病人，营养学家，医生助理，执业护士和医生。我们预料会有很多人出席这次会议。 在此资助申请中，我们介绍了该计划，会议的基本原理和本次国际研讨会的预期成果。资金对于这次会议的成功至关重要，这次会议将重塑美国和世界各地乳糜泻的未来。

DESCRIPTION (provided by applicant): The NIH Consensus Development Conference on Celiac disease (June, 2004) concluded that celiac disease occurs in about 1% of the United States population, though by far the majority are undiagnosed. Celiac disease is a unique autoimmune disease due to a genetically determined immune intolerance to gluten, the term for the storage proteins of wheat and similar grains. The only current treatment is a gluten-free diet. The Celiac Disease Center at Columbia University in New York will host the XII International Symposium on Celiac Disease in November 2006. This biannual event is the forum in which clinicians and investigators from around the globe meet to present current research and exchange knowledge about this disease. There is no Society to fund this event. The individual organizers in each country obtain funding. The recent NIH Consensus Conference, combined with an increase in scientific and clinical interest in celiac disease and an interest in the development on non-dietary therapies makes this Symposium an important event for the medical, scientific and pharmaceutical industry in the United States, occurring at a crucial time. In addition there is a great increase in interest in the diagnosis and management of celiac disease in both the developed and the developing world. We have organized an International Symposium involving the leaders in the field from around the world. In addition there will be a Clinical Forum designed for patients, nutritionists, physician assistants, nurse practitioners and physicians. We anticipate a large turnout for this meeting. In this grant application we present the program, rationale for the meeting and the expected outcomes of this International Symposium. Funding is crucial for the success of this meeting that will reshape the future of celiac disease both in this country and around the world.